|
|
|
Volumn 57, Issue 9, 1996, Pages 427-438
|
|
Choosing among old and new antipsychotics
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE RECEPTOR;
HALOPERIDOL;
NEUROTRANSMITTER RECEPTOR;
RISPERIDONE;
SERTINDOLE;
CAUDATE NUCLEUS;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
EXTRAPYRAMIDAL SYMPTOM;
HEALTH CARE COST;
HOSPITAL COST;
LOCOMOTION;
NEUROTRANSMISSION;
PARKINSONISM;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PUTAMEN;
RELAPSE;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
CLOZAPINE;
HUMANS;
PSYCHOTIC DISORDERS;
RECEPTORS, DOPAMINE;
RECEPTORS, NEUROTRANSMITTER;
RISK FACTORS;
RISPERIDONE;
SCHIZOPHRENIA;
|
|
EID: 0029784788
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
